Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer
Seung Tae Kim, Răzvan Cristescu, Adam Joel Bass et al. · Nature Medicine · 2018
Cited by 1,654 works. doi:10.1038/s41591-018-0101-z
Authors
- Seung Tae Kim
- Răzvan Cristescu
- Adam Joel Bass
- Kyoung‐Mee Kim
- Justin Iver Odegaard
- Kyung Kim
- Xiao Qiao Liu
- Xinwei Sher
- Hun Jung
- Mi-Jin Lee
- Se Hoon Park
- Joon Oh Park
- Young Suk Park
- Ho Yeong Lim
- Hyuk Lee
- Min Gew Choi
- AmirAli H. Talasaz
- Jonathan D. Cheng
References
- Fast and accurate short read alignment with Burrows–Wheeler transform
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
- Comprehensive molecular portraits of human breast tumours
- Signatures of mutational processes in human cancer
- Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples
- Comprehensive molecular characterization of gastric adenocarcinoma
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- The Ensembl Variant Effect Predictor
- First-Line Nivolumab in Stage IV or Recurrent Non–Small-Cell Lung Cancer